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Abstract 
Objective: Several medications have been used for sedation in children in dentistry and intra-nasal 
route has been reported to be an efficient way regarding patient cooperation. The aim of the present 
study was to compare the changes in physiologic parameters following intra-nasal midazolam and 
ketamine administration. 
Methods: In this randomized cross-over double-blind trial, 17 uncooperative 3-6 years old children 
requiring at least two dental treatments were selected randomly and received intra-nasal ketamine 
(0.5 mg/kg) and midazolam (0.2 mg/kg) prior to the treatment using the other drug in the next visit. 
Physiologic parameters including blood pressure, heart rate, respiratory rate and O2 saturation were 
measured and compared during the different time intervals using two way repeated measure 
ANOVA. 
Results: The patients showed higher blood pressure and heart rate following ketamine administration 
compared to midazolam (p<0.001). No significant difference was found between the drugs at 
different time intervals regarding respiratory rate and O2 saturation. (p>0.05) 
Conclusion: In spite of significant differences between midazolam and ketamine regarding heart rate 
and blood pressure, both drugs can b e used as effective sedative medications without treatment 
interruption in children. 
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According to common failures during dental 
treatments in children, utilization of a behavior 
control method including general anesthesia and 
conscious sedation is inevitable (1). Moreover, 
demands for sedation have been increased in 
recent years compared to general anesthesia (2). 
Different medications have been used as 
sedative agents in dentistry such as histamine, 
narcotics and benzodiazepine. Midazolam is a 
benzodiazepine with rapid onset and short 
duration. In anxious situations, it can  effectively 
 
calm children (3, 4). Ketamine, with the 
suggested dose of 3mg/kg in combination with 
other sedative drugs and 6mg/kg in situ, is also 
useful in dental treatments (5, 6). 
Several methods of drug administration like 
topical, intra-nasal, sublingual, rectal, intra and 
subcutaneous, intra-muscular, intra-pulmonary 
and inhalant have been introduced (4). Oral  
route is the most common way and has priority 
over other methods. In addition to its general 
acceptance, it is safe and inexpensive and its 
application is simple. On the other hand, young 
children do not accept it easily and its absorption 
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could be variable due to the presence of food, 
stomach autonomic tone, fear, emotional state, 
tiredness, drugs and stomach discharge intervals. 
Intra-nasal administration mostly is used in 
children in order to prevent oral or intra-venous 
routes. Intra-nasal drugs would be absorbed 
directly through vessels of nasal mucosa and do 
not enter the gastro-hepatic way. They have 
about the same onset of action as intra-venous 
administration with the plasma peak in about 10 
minutes. 
Parents/physician can drip the drug into the child 
nose with 1-3cc syringe without needle. 
Undiluted drug should be used in the nasal horn 
area to prevent its possible entrance to throat 
causing cough or sneeze (4). 
It has been demonstrated that rectal or oral drug 
administration have longer onset of actions 
compared to intra-nasal way (7). Intra-nasal drug 
administration is non-invasive and requires less 
cooperation. Although, some authors believe  
that it is stressful and children acceptance is less. 
Also, nasal mucosal irritation and burning are of 
its shortcomings. 
It has been reported that recovery after intra- 
nasal drug administration is faster than other 
methods although controversy exists (8). 
Moreover, variable results have been shown 
regarding physiologic parameter changes and 
even treatment interruption and O2 prescription 
have been reported (8, 9). 
So, the aim of the present study was to evaluate 
and compare the physiologic effects of intra- 
nasal midazolam and ketamine in uncooperative 




Ethical approval was obtained from Ethics 
Committee of Shahed dental school. In this 
crossover double-blind study, 17 uncooperative 
3-6 years old children meeting the inclusion 
criteria were selected. Informed consent was 
obtained  and  instructions  were  given  to   their 
 
parents. Parents informed that sedation 
procedure would be carried out by a specialist 
and a technician. 
Selected children showed negative attitude 
according to Frankel category, at least one 
dentist had confirmed their  noncooperation, 
were referred and also they required at least two 
identical dental treatments including pulpotomy 
and restoration/SS crown placement following 
local anesthesia. 
Children with the history of allergy to sedative 
drugs, upper airway infection, nasal obstruction, 
limitation of neck movements, macroglossia, 
tonsillar hypertrophy, micrognathia and 
limitation in mouth opening were excluded. 
Children were examined and a minimum of 6 
hours of NPO (Nothing per Oris) for solids and  
3 hours for liquid was suggested. No sign of 
fever, cough or sneezing should be observed 
during examination. Children were assigned to 
groups A and B, randomly. At first visit (after 
completion of questionnaire), a thorough history 
and demographic information with child’s 
weight were obtained. Health status was 
determined and physiologicparameters including 
heart rate, respiratory rate, blood pressure and O2 
saturation recorded with pulse oxymeter 
(CHOICEMED, China) and pressure gauge 
(Mediasave, UK) as basic records. 
After administration of 1cc lidocaine 
hydrochloride 2% (Pastur-Industrial Company of 
Iran) combined with 0.25 mg atropine 
(Aburaihan Industrial Company Tehran-Iran) in 
order to reduce tingle, each group received intra- 
nasal ketamine (Chemidaru Industrial Company 
Tehran-Iran) (0.5 mg/kg) and midazoalm 
(Chemidaru Industrial Company Tehran-Iran) 
(0.2 mg/kg) in two subsequent dental visits. The 
procedure was carried out with the presence of 
parents and in either upright or supine position 
according to patient cooperation. Each patient 
was used as his/her own control. 
Physiologic parameters at first, before sedation 
(T0),  during  administration  of  anesthesia   (10 
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minutes after administration of sedative agent) 
(T1), 5 and 15 minutes after local anesthesia 
administration (T2 and T3) and at the discharge 
time (T4) were recorded. At the end of  
treatment, children were transferred to recovery 
room and watched over to observe discharge 
criteria which were defined as follows: 
1) Stable and acceptable heart function. 
2) Normal breathing. 
3) Normal response to stimulations and 
healthy protective reactions. 
4) Ability to sit and talk. 
5) Presence of child’s caretaker. 
Parents were questioned about the complications 
and their satisfaction 24 hours after discharge 
and the second dental visit was settled. 
SPSS version 19 was used to analyze data. Mean 
 
and standard deviation (SD) at different time 
intervals evaluated using two-way repeated 
measure ANOVA. Data were suggested to be 




17 children (9 males: 52.9% and 8 females: 
47.1%) with the mean age of 4.5 (0.9) and ASA 
I physical status were studied. The mean weight 
of children was 16.2 (3.6) kg with the range of 
24 (10.5) kg. The reason of sedation in 15 
children was fear and anxiety and in other two 
was under development and young age. 
Table 1 shows the mean and SD of four 
physiologic parameters. 
 


















According to Diagram 1, heart rate differences 
following ketamine administration between T0 
and T1 are almost the same and shows 
significant difference compared to three other 
time points. (T2, T3 and T4) (p<0.05). 
Diagrams 2 and 3 reveal that changes in O2 
saturation and respiratory rate were not 
significantly different between two drugs and at 
different time intervals, respectively (p>0.05). 
Increase  in  blood  pressure  following ketamine 
administration was significantly higher  
compared to midazolam. (Diagram 4) Moreover, 
blood pressure changes at different time 
intervals were significantly higher than that of 
ketamine administration (p<0.05), while 
midazolam resulted in significant difference in 
blood pressure only at T2 (p<0.05). It means that 
the most increase in blood pressure happens 5 
minutes after local anesthesia administration 
using midazolam. 
Time Medication mean SD mean SD mean SD mean SD 
  Heart rate Oxygen saturation Respiratory rate Blood pressure 
Before drug Ketamine 123.5 12.7 97.0 0.007 25.1 1.8 109.9 4.3 
administration Midazolam 124.3 11.7 97.0 0.009 24.9 2.2 110.6 5.2 
At local 
Ketamine 130.5 12.8 97.0 0.006 24.1 2.0 117.6 4.7 
anesthesia 
Midazolam
 126.3 12.4 97.0 0.006 24.5 2.1 113.3 5.3 
5th minute 
Ketamine 130.5 12.4 97.0 0.006 24.4 1.8 120.1 4.4 
Midazolam 125.1 12.7 95.0 0.07 24.4 2.0 113.7 4.9 
15th minute 
Ketamine 128.6 13.2 97.0 0.006 24.6 1.9 118.7 5.1 
Midazolam 125.6 13.5 97.0 0.008 24.8 1.6 112.5 6.3 
Ketamine 126.4 12.0 97.0 0.008 24.8 1.9 116.0 5.6 
Discharge time 
Midazolam
 123.3 13.6 97.0 0.007 24.3 1.8 110.7 6.8 
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Diagram 1- Heart rate changes following intra-nasal sedation with ketamine and midazolam at different time 
intervals 
 
Diagram 2- Oxygen saturation changes following intra-nasal sedation with ketamine and midazolam at 
different time intervals 
 
 
Diagram 3- Respiratory rate changes following intra-nasal sedation with ketamine and midazolam at 
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It is well-known that sedative agents would be 
helpful in behavior control and ease of dental 
operation in children. (10, 11) In the present 
study, we compared the effects of intra-nasal 
midazolam and ketamine on physiologic 
parameters of 3-6 years old uncooperative 
children. 
The results show that differences in heart rate 
before drug administration were not significant 
while during local anesthesia administration, 5 
and 15 minutes after anesthesia administration 
and at the discharge time, the mean heart rate 
following ketamine use was significantly higher 
than midazolam. On the other hand, the mean 
blood pressure found to be significantly higher  
at local anesthesia administration, 5 and 15 
minutes after anesthesia administration 
following ketamine compared to midazolam. No 
significant differences observed regarding O2 
saturation and respiratory rate between two 
medications at different time intervals. 
Researches on the conscious sedation using 
ketamine and midazolam have demonstrated the 
increase in heart rate subsequent to their 
administration (12, 13). It is obvious that 
children would experience the increases in heart 
rate, partly due to the stressful situation    during 
dental treatment (12). Ketamine could result in 
slow increase in heart rate and blood pressure 
which has little clinical effects (13, 14). 
Golpayegani, et al. (2012) compared the 
combination of oral midazolam-ketamine with 
midazolam-prometazine in 2-6 years old  
children and reported that after 30 minutes, the 
heart rate increased significantly following 
ketamine administration (p=0.03) (15). 
Consistently, Lotfy, et al. (1970) stated that 
increase in arterial blood pressure and heart rate 
is the definite and usual effects of ketamine in 
children which implies the stimulation of 
sympathic system (16). 
Tobias and Leder (2011) demonstrated that 
ketamine has limited effects on respiratory 
system while it results in dose-dependent 
increase in heart rate and blood pressure due to 
sympatethic stimulation and release of 
endogenous catecholamines. Also, they reported 
that increase in blood pressure and tachycardia 
following its administration, could be decreased 
by combining the drug with barbiturates or 
benzodiazepine (17). 
Wilton, et  al.  (1988)  compared  0.3  mg/kg and 
0.2 mg/kg intra-nasal midazolam in 1.5-5 years 
old children and found no difference in O2 
saturation or respiratory rate. They concluded 
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result in adequate sedation in pre-school children 
(18). 
Weldon, et al. (1992) also reported that no 
significant difference was observed in heart rate, 
respiratory rate or hemoglobin O2 saturation 
following Atropine or midazolam in children 
(19). 
Conversely, Tanaka, et al. (2000) found no 
significant difference in heart rate and blood 
pressure changes between rectal administration 
of ketamine and midazolam. This can be 
explained by greater and faster drug absorption 
by through intra-nasal administration compared 
to rectal route (20). 
Also, von Ungern-Sternberg, et al. (2009) stated 
that oral midazolam in children whit healthy 
respiratory system, would result in slight  
changes in respiratory variables for short 
duration and the caregiver should notice that 
drug administration in children with impaired 
respiratory function leads to greater functional 
deficiency (21). 
Tavassoli-Hojjati, et al. (2014) demonstrated  
that oral and buccal administration of midazolam 
does not result in significant changes in 
physiologic   parameters   after   10,   20   and 30 
 
minutes (22). 
Intra-nasal drug administration is reported to 
produce more effective and rapid sedation due to 
direct drug absorption, better biologic access and 
obtaining faster plasma peak. Moreover, 
according to rapid drug excretion, sedative effect 
would decrease at the end of treatment. 
Vomiting is one of the common complications 
after intra-nasal ketamine administration  
(35.3%) which could be related to swallowed 
drug. This complication is temporary and has 




Changes in O2 saturation and respiratory rate 
showed no significant differences between intra- 
nasal ketamine and midazolam and at different 
time intervals. In spite of significant increase in 
heart rate and blood pressure following ketamine 
administration, there is no need to interrupt 
treatment procedure and both drugs induce 
adequate sedation in children. 
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